Langerhans Cell Histiocytosis with Good Response to Low-Dose Imatinib: Case Report and Literature Review.

Abdulgayoom M, Mudawi D, Lengyel Z, Abo Samra H, Alshurafa A, Yassin MA

DOI: 10.1159/000531230
Published: 2023 Jan-Dec
Container: Case reports in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1159/000531230,
  title = {Langerhans Cell Histiocytosis with Good Response to Low-Dose Imatinib: Case Report and Literature Review.},
  author = {Abdulgayoom M and Mudawi D and Lengyel Z and Abo Samra H and Alshurafa A and Yassin MA},
  year = {2023},
  journal = {Case reports in oncology},
  doi = {10.1159/000531230},
  url = {https://doi.org/10.1159/000531230}
}

RIS

TY  - JOUR
TI  - Langerhans Cell Histiocytosis with Good Response to Low-Dose Imatinib: Case Report and Literature Review.
AU  - Abdulgayoom M
AU  - Mudawi D
AU  - Lengyel Z
AU  - Abo Samra H
AU  - Alshurafa A
AU  - Yassin MA
PY  - 2023
JO  - Case reports in oncology
DO  - 10.1159/000531230
UR  - https://doi.org/10.1159/000531230
ER  -

APA

M, A., D, M., Z, L., H, A. S., A, A., & MA, Y. (2023). Langerhans Cell Histiocytosis with Good Response to Low-Dose Imatinib: Case Report and Literature Review.. Case reports in oncology. https://doi.org/10.1159/000531230

Source records

pubmed · retrieved 2026-09-25T04:31:06.259Z